`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`FLATWING PHARMACEUTICALS, LLC and
`MYLAN PHARMACEUTICALS, INC.,
`Petitioners,
`
`v.
`
`ANACOR PHARMACEUTICALS, INC.,
`Patent Owner.
`
`
`Case Nos. IPR2018-00168, -00169, -00170, and -001711
`
`U.S. Patent Nos. 9,549,938, 9,566,289, 9,566,290, and 9,572,823
`______________________
`
`PETITIONER’S NOTICE OF DEPOSITION OF
`PAUL J. REIDER, PH.D.
`
`
`
`
`
`
`
`
`1 Case Nos. IPR2018-01358, -01359, -01360, and -01361 have been joined with
`these proceedings.
`
`
`
`
`
`In accordance with 37 C.F.R. § 42.53, Petitioner FlatWing Pharmaceuticals,
`
`LLC, by and through its attorneys, will conduct cross-examination by deposition of
`
`Paul J. Reider, Ph.D. beginning at 9:00 AM EDT on November 9, 2018, at the
`
`offices of Williams & Connolly LLP, Washington, D.C., or at such other time and
`
`place as the parties may agree.
`
`The deposition will continue day to day until concluded, and will be
`
`recorded stenographically by an officer authorized to administer oaths. Counsel
`
`are invited to attend.
`
`
`
`
`
`
`
`October 29, 2018
`
`
`
`
`
` Respectfully submitted,
`
`
`/Philip D. Segrest Jr./
`Philip D. Segrest Jr. (Reg. No. 39,021)
`philip.segrest@huschblackwell.com
`Lead Counsel for Petitioner
`Eric J. Rakestraw (Reg. No. 68,740)
`Eric.Rakestraw@HuschBlackwell.com
`PTAB-ERakestraw@HuschBlackwell.com
`Back-up Counsel for Petitioner
`Edward D. Manzo (Reg. No. 28,139)
`Edward.Manzo@HuschBlackwell.com
`Additional Back-up Counsel for Petitioner
`HUSCH BLACKWELL LLP
`120 South Riverside Plaza, Suite 2200
`Chicago, IL 60606
`Tel. 312-655-1500
`Fax. 312-644-1501
`
`1
`
`
`
`FlatWing Pharmaceuticals, LLC, v. Anacor Pharmaceuticals, Inc.
`Cases Nos. IPR2018-00168, -00169, -00170, and -00171
`Patents Nos. 9,549,938, 9,566,289, 9,566,290, and 9,572,823
`
`
`CERTIFICATE OF SERVICE
`
`
`
`The undersigned hereby certifies that a copy of the foregoing
`
`document was served via electronic mail on the following attorneys of
`
`record:
`
`Aaron P. Maurer,
`amaurer@wc.com
`David I. Berl,
`dberl@wc.com
`tselby@wc.com
`asheh@wc.com
`Counsel for Patent Owner
`Anacor Pharms., Inc.
`
`
`On this the 29th day of October 2018.
`
`Steven Parmelee,
`sparmelee@wsgr.com
`Michael Rosato,
`mrosato@wsgr.com
`Jad Mills
`jmills@wsgr.com
`Counsel for Petitioner Mylan
`Pharms., Inc.
`
`
`
`
`
`
`
`
`/Philip D. Segrest Jr./
`Philip D. Segrest Jr. (Reg. No. 39,021)
`philip.segrest@huschblackwell.com
`Lead Counsel for Petitioner
`Eric J. Rakestraw (Reg. No. 68,740)
`Eric.Rakestraw@HuschBlackwell.com
`PTAB-ERakestraw@HuschBlackwell.com
`Back-up Counsel for Petitioner
`Edward D. Manzo (Reg. No. 28,139)
`Edward.Manzo@HuschBlackwell.com
`Additional Back-up Counsel for Petitioner
`HUSCH BLACKWELL LLP
`120 South Riverside Plaza, Suite 2200
`Chicago, IL 60606
`Tel. 312-655-1500
`Fax. 312-644-1501
`
`